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In recent years, the interest of the scientific world towards vitamin D gradually increased, and several studies have
been conducted to dissect its possible role in modulating the development/course of allergic diseases. Also,
Vitamin D supplementation has been assessed as a beneficial approach for treating allergies in some, but not all
studies. We reviewed herein the available and relevant literature concerning the possible links between Vitamin D,
its supplementation and allergic diseases. A literature search was made independently by the Authors, identifying
articles for a narrative review. As per literature, Vitamin D plays a key role in calcium and phosphate metabolism,
and it is essential for bone health in infants, children and adolescents. However, there is presently insufficient
evidence to support vitamin D supplementation for prevention or treatment of allergic diseases in infants, children
and adolescents, concerning allergic rhinitis, asthma, food allergy and atopic dermatitis.
Keywords: Vitamin D, Allergic diseases, Immunomodulation, Supplementation, Asthma, Rhinitis, Pediatric allergyGeneral background
During the two last decades, the scientific interest on
the Vitamin D system progressively increased. Apart
from the well-known role of this vitamin in bone and
calcium metabolism, recent observations have suggested
its possible role as a pivotal immune-modulator also in
allergic diseases, including asthma [1], and this aspect
could assume a particular relevance in pediatric patients.
A growing body of literature underlined that vitamin D
plays an important role in the general function/regulation
of immune system, expecially concerning lymphocyte
function, T cell antigen receptor signaling and activa-
tion, cytokine production [2-4]. Based on these obser-
vations, the vitamin has been suggested as a potential
factor affecting incidence, severity and course of asthma
and allergic diseases [5,6], thus envisaging also prevent-
ive roles. It is also true that some studies suggested that
high serum levels of vitamin D may increase the risk
of allergic disorders [7-12]. Cholecalciferol, and its
metabolites, are more properly hormones that can be
synthesized by the human body (Figure 1). Ultraviolet* Correspondence: passalacqua@unige.it
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article, unless otherwise stated.radiations determine the photochemical conversion in
the skin of 7-dehydrocholesterol into cholecalciferol
(Vitamin D3). Subsequently, in the liver, mitochon-
drial and microsomal enzymes similar to cytochrome
P450 determine its hydroxylation in position 25 to get
25-hydroxy-cholecalcipherol (calcidiol), that is usually
named and assayed as Vitamin D (VD) since it represents
the most abundant circulating form, with a long half-life.
Approximately, 88% of VD circulates bound to specific
binding proteins, or bound to albumins, whereas only
0,03% is free. The second hydroxylation, that is necessary
for having an active hormone, occurs in kidney, where
VD is converted in the active form (1–25 hydroxyVD,
calcitriol) [13].
Up to recent times, it was argued that the conversion
of VD into its active metabolite could exclusively occur
in the kidney. Latest discoveries have brought to light
how other cells in different organs express receptors for
vitamin D. Typical examples are represented by T and B
lymphocytes, monocytes, antigen presenting cells (APC)
including macrophages and dendritic cells [14]. In the
matter of this, it is established that vitamin D exerts its
effects on the immune system, especially increasing the
expression of cathelicidins hCAP18, important defense
factor against pathogens of the respiratory tract [15].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 General metabolism of vitamin D, precursors and derivatives.
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after a signal mediated by inflammatory cytokines, would
seem to determine the chemotaxis of the cells of in-
nate immunity by activating an inflammatory response
against several microorganisms. Moreover, vitamin D
may stimulate the production of cationic peptides, beta-
defensin 2 and 4 [15].
The supposed antiallergic effects of VD may in part
be ascribable to the action on dendritic cells, favoring
the production of IL-10 and reducing the production of
IL-12 [16]. A serum level of VD ≥ 50 nmol/L is considered
sufficient, values < 50 nmol/L insufficient, and < 40 nmol/L
possibly at risk for disease. To ensure an adequate in-
take of vitamin D, the American Academy of Pediatry
has raised the daily recommended intake for children
and adolescents [17], to a dose of 400 IU up to 12 months
of age and 400–600 over 12 months [18], recommending
that this supplementation should begin during the first
days of life.
Concerning allergic diseases, the available studies pro-
vided conflicting results. Certainly, in addition to serum
levels of VD, other factors may play a crucial role in the
development of allergies and asthma, including environ-
ment and genetics. In this regard, an interesting aspect
concerns the latitude [19]: high latitudes (evaluated in con-
sideration of residence at time of birth and interview),
which are characterized by lower ultraviolet irradiation,
may be associated with a lower frequency of allergy, while
a higher ultraviolet exposure (lower latitudes), was associ-
ated with an increased likelihood of having a history of
allergic rhinitis or asthma or both conditions during child-
hood. Of course, these represent only a cross-sectional
study, and do not provide a direct evidence that sun-
exposure is related to VD and allergy.Interventional studies with VD in patients with
immune-mediated diseases were not fully exhaustive.
The extent of involvement of vitamin VD-dependent
and VD-independent pathways in homeostasis and regu-
lation of immune system in diseases still needs to be ex-
plored [20].
Vitamin D and allergic rhinitis
There are few studies related to allergic rhinitis. An
Australian study [21] after observing that the prevalence
of allergies increases in percentage, with the decrease of
latitude, tried to describe each latitudinal variation in the
prevalence of allergy in childhood and to assess, in paral-
lel, the possible association between ultraviolet irradi-
ation and VD, in relation with allergic rhinitis, asthma, or
both conditions. The conclusions have shown that the in-
verse association between latitude and asthma is not
dependent on ultraviolet but attributable to other cli-
matic factors such as temperature. It was also reported
that supplementation with cod liver oil before 15 years of
age is associated with an increased likelihood of having
asthma and allergic rhinitis. Another study performed in
Norway displayed a direct association between VD defi-
ciency and male sex for the development of allergic rhin-
itis, whereas females resulted protected according to VD
levels [22]. The research provides a rationale for the
evaluation of the possible central role of early vitamin D
supplementation for the development of allergy in child-
hood. Different patterns of sun exposure are probably
also involved in allergic sensitization.
Vitamin D, asthma and wheezing
Concerning the relationship between VD and wheezing,
a prenatal VD deficiency seems to predispose to
Table 1 Potential mechanisms of interaction between
vitamin D and GC
- Enhanced dexamethasone (DEX)-induced expression of IL- 10 by T
regulatory cells
- Preincubation of T cells with both IL-10 and vitamin D3 overcame
defects in DEX-induced CD41 T cell IL-10 production
- Possible mechanism in which vitamin D3 reversed ligand-induced
down-regulation of the GC receptor
- High concentrations of vitamin D were instead put in relation with
the increased expression of MPK-1 protein by blood mononuclear
cells
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affecting the development of the lung as well as of
the fetal immune system [11]. An adequate intake of
VD during pregnancy would seem to exert a protect-
ive action on the onset of childhood wheezing and
asthma, especially in the male offspring [23]. This
appears to be due to the synergistic action of VD
and 17-beta-estradiol, with a final reduction of the
catabolism of VD [24]. Children born from mothers
with VD deficiency during pregnancy are predisposed
to an increased risk of recurrent wheezing at 3 years
of age. The additional intake of 100 IU of vitamin D
in the first and second trimester of pregnancy is as-
sociated with a lower risk of asthma and wheezing
during childhood [9]. The possible influence of
genotype-associated VD binding proteins, makes the
link between asthma and VD even more complex
[25].
Asthma, in its allergic phenotype, is classically deter-
mined by an increased activity of TH2 cells resulting in
the production of IgE and inflammatory cytokines caus-
ing airway hyperresponsiveness with a predominantly
eosinophilic inflammation. In recent years, many studies
focused the possible protective role of vitamin D against
bronchial asthma [26]. Nonetheless in a Spanish birth
cohort, higher maternal VD at 12 weeks’ gestation was
not associated with wheezing at 1 year or 4 years or
asthma at age 4 to 6 years [7]. Also, a recent study from
UK found no association with dietary vitamin D and
wheeze, asthma, or sensitization [8]. Using either mater-
nal or cord blood as biomarker for fetal VD exposure,
an inverse associations with the risk of developing re-
spiratory and allergic disease was found [9-12].
Gupta et al. showed an inverse relationship between
serum concentration of VD and severity of asthma at-
tacks, number of exacerbations and consumption of in-
haled corticosteroids (ICS); the same study also showed
how optimal levels of VD were associated with a good
control of the disease [27]. Searing et al. observed that
children with asthma had overall insufficient serum
levels of vitamin D, with an inverse correlation between
VD, total IgE and skin prick tests (SPT) positivity, and a
direct association with increased corticosteroid usage
[28]. From a functional point of view, it has also been
shown that a deficiency state involves the reduction of
the forced expiratory volume in the 1st second (FEV1)
in patients with mild to moderate asthma.
VD would also modulate various cytokines induced ef-
fects through different cells of the immune system with
a dose-dependent action. Reasonable doses of VD inhibit
the production of both TH1 and TH2 cytokines, while
high concentrations seem to even amplify the TH2
responses [29]. Moreover, VD, in association with gluco-
corticoids, may increase directly or indirectly theproduction of anti-inflammatory cytokines such as IL 10
[30]. Concerning the airway remodeling in asthma, some
studies showed that VD can affect remodeling through
a direct effect on the proliferation of smooth muscle
cells of the airways, also influencing their growth and
contractility [31].
Vitamin D and steroid resistance
The molecular mechanisms of glucocorticoid resistance
in children are probably different, unclear and not yet
clearly defined. A congenital steroid resistance, resulting
from any genetic mutation of the receptors is rare [32].
On the contrary, acquired resistance is more common,
and often can be overcome by increasing the dose, this
increasing also the risk of side effects. There are several
potential mechanisms underlying resistance to steroid
therapy that have been mainly studied in adult subjects
[33,34]. The pathophysiological mechanism underlying
allergic responses involves the initial participation of
the innate immunity APC resulting in the activation of
the TH2 lymphocytes response. The regulatory T cells,
through the production of cytokines such as IL-10 and
TGF-beta, negatively modulate the activation of this im-
mune response that contribute to airways inflammation
and hyperreactivity. A functional reduction of the regu-
latory T lymphocytes activity has been associated with
the resistance to glucocorticoid therapy as well [35].
More recently, several Authors underlined that VD
may be involved in the increase of regulatory T lympho-
cytes recruitment [36]. In conditions of VD deficiency
regulatory T-lymphocytes were reduced not only in
number but in overall functionality and effectiveness. A
small pilot study has also suggested that the intake of
VD in people with asthma would increase the response
to therapy with dexamethasone [36]. We could than as-
sume that vitamin D may potentially increase the thera-
peutic response to glucocorticoids in those subjects that
exhibit resistance to steroids.
Some mechanisms (Table 1) have been proposed to ex-
plain how VD can interact with steroid therapy. Suther-
land et al. [37] showed an association between low levels
of vitamin D and impaired lung function, increase of
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oid response in a group of patients with moderate to severe
asthma. VD can also modulate at genomic level the tran-
scription of genes for proteins with inflammatory activity
[38-40]. Another mechanism potentially involved in steroid
resistance is the ability of VD to adjust the expression of
genes involved in inflammatory phenomena, in relation to
the regulation of glucocorticoid receptors themselves [41].
In vitro, physiological concentrations of VD added to
dexamethasone significantly increase the expression of
proteins MPK-1 in peripheral blood mononuclear cells
compared to dexamethasone alone, suggesting that the
addition of vitamin D could reduce the effective dose
of dexamethasone required. Hence, it is important to
emphasize that a treatment with vitamin D in an asth-
matic patient may not only lead to a significant improve-
ment in clinical symptoms, but also to a tapering of
the steroid dose thus avoiding the well-known side
effects [38].
Vitamin D and asthma exacerbations
It is well known that viral infections of the respiratory
tract lead to an increase of asthma exacerbations both in
children and in adults [42]. Rhinovirus infections, for
example, induce an inflammatory state in the airways,
not only increasing the severity of asthma exacerbation,
but also leading to infections running definitely with a
greater severity than in non asthmatic patients [42].
Emerging new evidences brought to light as subjects
with inadequate intake of vitamin D exhibit a higher
number of respiratory infections per year and that these
may onset with greater severity [43].
One prospective cohort study measured the different
concentrations of VD in 198 adult subjects observing
how individuals with VD concentrations less than
38 ng/mL had a risk of viral infections of the respiratory
tract doubly increased [44]. The EDEN [45] cohort study
found no significant association between cord-blood VD
levels and the risk of developing asthma. Also, it was
evidenced that a VD deficiency status make more prone to
exacerbations of asthma children than adults [45-47]. Ac-
cording to these data it is clear how important is an early
identification of vitamin D deficiency status, and also a
prompt setting of adequate supplementation, to prevent
several diseases both in adults and in children.
Vitamin D and food allergy
Although the extra-skeletal role of VD is definitely intri-
guing and should not be underestimated, at this moment
there is a lack of consistent data facing the issue of
VD in the development/prevention of food allergies.
One recent cross-sectional study [48] on more than
500 infants with proven food allergy showed a direct
relation with VD deficiency and disease, although moredetailed immunological parameters (e.g. food-specific
immunoglobulins) were not investigated. Another study
evidenced that high vitamin D levels in pregnancy and at
birth may contribute to a higher risk for food allergy [49],
this standing against VD supplementation to protect
against allergy. Another birth cohort study on 650 infants
could not detect an epidemiological relation between VD
deficiency and risk of food allergy, although an associ-
ation with specific genetic assets was seen [50]. Consider-
ing the large amount of literature regarding the
mechanisms associated with atopic diseases, an evalu-
ation of serum levels of VD and finally its supplementa-
tion must be regarded as a further opportunity to
understand and treat atopic diseases, but well-designed
studies on VD supplementation to prevent food allergies
are needed [51].
Vitamin D and atopic dermatitis
Some studies on this subject indicated an inverse rela-
tionship between the prevalence and/or severity of
atopic dermatitis and VD levels. Furthermore, studies
have shown that, in individuals with dermatitis and VD
deficiency, a supplementation reduces the severity of the
disease [52,53]. However, data are not consistent, as this
correlation has been found, but only in patients with al-
lergic sensitization [54,55], and other studies found no
or an inverse correlation between VD deficiency and
atopic eczema [56,57]. In addition, a recent controlled
trial found no visible effect of VD supplementation on
clinical severity of the disease [58]. Of note, cathelicidin,
an antimicrobial innate protein, is presently regarded as
a possible biomarker linking VD and innate immune
regulation in atopic dermatitis [59,60].
Vitamin D and anaphylaxis
It would seem to exist an interesting relationship be-
tween latitude and episodes of anaphylaxis as reported
in the records of the emergency rooms and the sales of
self-injectable epinephrine. In his study Mullins showed
that both parameters were higher in the southern re-
gions of Australia [61]. Nonetheless, a clear and direct
relationship within VD and anaphylaxis has been so far
demonstrated or explored in detail.
Concluding remarks
Taken together the available literature, it is not yet pos-
sible to confirm or refute the direct role of VD in the de-
velopment/worsening of allergic diseases in pediatric age
and in newborns, neither to assign a relevant role to VD
use in an immunological therapy setting. Many con-
founding and still unidentified variables are present in
the various studies. There is an overwhelming experi-
mental evidence that vitamin D acts on the function of
immune cells, but the complexity of this system, cannot
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tritional guideline can be issued in the setting of allergy.
Also, it is not yet possible to recommend an absolute
strategy for the use of VD in the therapy of asthma and
allergic diseases, or in prevention [62-65]. Clinical trials
and population-based prospective studies are needed, in
order to better understand the molecular mechanism by
which VD may affect immunological disorders and their
development. [3]. VD plays a key role in calcium and
phosphate metabolism and is essential for bone health in
infants, children and adolescents; however, up to now
there is insufficient evidence to support vitamin D sup-
plementation to obtain other benefits [58]. In conclusion,
pediatricians should pay closer attention to vitamin D
levels in allergic children and their parents for a better dis-
ease management.
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